AnalystsYaron WerberYaron Werber's Stock Forecasts
AnalystsYaron Werber
Sectors:
Industries:
Analyst Ranking
Bottom 5%
#4564 out of 4753 analysts
Average Return
-7.48%
Win Rate
45%14 out of 31
Risk vs Reward
Poor
Good
Yaron Werber's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Exelixis IncEXEL | +62.33% | $21.93 | $35.59 | 2024-05-01 - 2024-12-02 | Strong Buy |
Beigene LtdBGNE | +42.76% | $144.12 | $205.75 | 2024-04-24 - 2024-12-02 | Strong Buy |
Argenx SeARGX | +36.42% | $452.63 | $617.49 | 2023-12-12 - 2024-12-02 | Buy |
Legend Biotech CorpLEGN | +29.52% | $51.01 | $66.07 | 2022-11-01 - 2023-10-31 | Buy |
Amgen IncAMGN | +27.54% | $246.41 | $314.26 | 2023-02-01 - 2024-01-31 | Buy |
Yaron Werber Analyst Color
Get additional color on Yaron Werber's coverage of popular stocks
Yaron Werber's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Ascendis Pharma AASND | 5 | Strong Buy | $153.00 | +14.60% | Maintains | 18 days ago |
Beigene LtdBGNE | 5 | Strong Buy | $260.00 | +26.37% | Maintains | 20 days ago |
Biontech SeBNTX | 5 | Hold | $122.00 | +4.10% | Maintains | a month ago |
Ultragenyx Pharmaceutical IncRARE | 2 | Strong Buy | $73.00 | +53.36% | Maintains | a month ago |
Exelixis IncEXEL | 2 | Strong Buy | $34.00 | -4.47% | Maintains | a month ago |
Amgen IncAMGN | 5 | Strong Buy | $383.00 | +37.72% | Maintains | a month ago |
Ionis Pharmaceuticals IncIONS | 1 | Strong Buy | $59.00 | +63.43% | Maintains | 4 months ago |
Legend Biotech CorpLEGN | 2 | Strong Buy | $67.00 | +54.70% | Maintains | 5 months ago |
Argenx SeARGX | 3 | Buy | $641.00 | +3.81% | Maintains | a year ago |
Fibrogen IncFGEN | 1 | Hold | $25.00 | N/A | Maintains | 2 years ago |
Instil Bio IncTIL | 2 | Hold | N/A | N/A | Downgrades | 2 years ago |
Genmab AGMAB | 1 | Hold | $38.00 | N/A | Initiates Coverage On | 3 years ago |
Bluebird Bio IncBLUE | 1 | Hold | N/A | N/A | Downgrades | 3 years ago |
2seventy Bio IncTSVT | 1 | Buy | N/A | N/A | Initiates Coverage On | 3 years ago |
Io Biotech IncIOBT | 1 | Buy | N/A | N/A | Initiates Coverage On | 3 years ago |
Roivant Sciences LtdROIV | 1 | Buy | N/A | N/A | Initiates Coverage On | 3 years ago |
Acceleron Pharma IncXLRN | 1 | Hold | $180.00 | N/A | Downgrades | 3 years ago |
Immuneering CorpIMRX | 1 | Buy | N/A | N/A | Initiates Coverage On | 3 years ago |
Dicerna Pharmaceuticals IncDRNA | 1 | Hold | N/A | N/A | Downgrades | 3 years ago |
Nuvation Bio IncNUVB | 1 | Buy | N/A | N/A | Initiates Coverage On | 4 years ago |
Regeneron Pharmaceuticals IncREGN | 1 | Buy | $565.00 | N/A | Maintains | 4 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.